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The goal of the study is to determine the extent of structural
brain abnormalities in a multicenter sample of children and
adolescents with a recent-onset first episode of psychosis
(FEP), compared with a sample of healthy controls. Total
brain and lobar volumes and those of gray matter (GM),
white matter, and cerebrospinal fluid (CSF) were measured
in 92 patients with a FEP and in 94 controls, matched for
age, gender, and years of education. Male patients (n 5
64) showed several significant differences when compared
with controls (n5 61). GM volume in male patients was re-
duced in the whole brain and in frontal and parietal lobes
compared with controls. Total CSF volume and frontal,
temporal, and right parietal CSF volumes were also in-
creasedinmalepatients.Withinpatients, thosewithafurther
diagnosis of ‘‘schizophrenia’’ or ‘‘other psychosis’’ showed
a pattern similar to the group of all patients relative to con-
trols. However, bipolar patients showed fewer differences
relative to controls. In female patients, only the schizophre-
nia group showed differences relative to controls, in frontal
CSF. GM deficit in male patients with a first episode corre-
lated with negative symptoms. Our study suggests that at
least part of the GM deficit in children and adolescent-onset
schizophrenia and in other psychosis occurs before onset of
the first positive symptoms and that, contrary to what has
been shown in children-onset schizophrenia, frontal GM
deficits are probably present from the first appearance of
positive symptoms in children and adolescents.
Key words:MRI/first-episode psychosis/early-onset
psychosis/brain morphometrics
Introduction
Patients with first-episode early-onset psychosis (first ep-
isode before 18 years of age with an onset of less than 6
months of positive symptoms before baseline assessment)
may constitute a quite homogenous group to study, re-
garding the absence of course-related effects, such as du-
ration and treatment. Cross-sectional magnetic resonance
imaging (MRI) studies have demonstrated that child-
hood-onset schizophrenia is associated with smaller
whole-brain and total gray matter (GM) volume, thinner
cortical thickness, and larger ventricular volume than
controls.1–4 Longitudinal studies have shown a back-to-
front wave of GM loss in children with schizophrenia re-
sembling the normal development pattern but in an exag-
gerated manner.5,6 In particular, parietal and motor
cortex deficits have been shown at baseline while prefron-
tal, supplementary motor, sensorimotor, parietal, and
temporal deficits appeared or increased the deficit over
time.5 The few studies that have scanned adolescent-onset
schizophrenia patients show decreased frontal (but not
parietal or temporal) GM volumes and increased total
and frontal cerebrospinal fluid (CSF) at onset.7–9
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The specificity of these findings for schizophrenia has
not been thoroughly investigated. Bipolar disorder
patients frequently share many of the psychotic symp-
toms associated with schizophrenia. Thus, analysis of
structural abnormalities in bipolar patients with psy-
chotic symptoms and schizophrenia patients will shed
light on the specificity of brain changes in the context
of pathological processes related to psychosis.
The present study builds on earlier reports demonstrating
brain abnormalities in adolescent-onset psychosis patients
with a recent-onset first episode of psychosis (FEP).7,10 The
objective was now to extend the study to a much larger, in-
dependent, and representative sample by recruiting subjects
from 5 psychiatric units. Our sample includes a matched
comparison group of healthy children and adolescents
from each participating center to control for potential de-
mographic factors known to affect brain morphometry.
The main hypothesis of the study was that children and
adolescents with first psychotic episodes will show volumet-
ric differences inGMandCSF of themain brain lobes, par-
ticularly in the frontal. Furthermore, the goal of this article
using a larger data set is to allow for subdivision of patients
into diagnostic groups within psychosis.
Methods
Subjects
The sample used in this study consisted of 92 patients (28
females) and 94 controls (33 females), participating in the
Child and Adolescent First-Episode Psychosis Study
(CAFEPS).11 CAFEPS included patients from 6 different
psychiatric units.
The inclusion criteria for patients were age between 7
and 17 years at the time of first evaluation and positive
psychotic symptoms (within a psychotic episode) such as
delusions or hallucinations of less than 6-month dura-
tion. Exclusion criteria were a concomitant Axis I disor-
der at the time of evaluation that might account for the
psychotic symptoms, mental retardation as per the Diag-
nastic and Statistical Manual of Mental Disordes (Fourth
Edition) (DSM-IV) criteria, pervasive developmental dis-
order, neurological disorders, history of head trauma
with loss of consciousness, pregnancy, and drug-induced
psychosis. When drugs were positive in the urine baseline
assessment, we included the patient in the study if symp-
toms persisted 2 weeks after a negative urine test. Eight
patients and 1 control fulfilled DSM-IV criteria for can-
nabis abuse. All the patients maintained psychotic symp-
toms 15 days after a negative urine test and did not fulfill
criteria for drug-induced psychosis. Only 1 patient at re-
cruitment abused cocaine, 1 abused alcohol, and 1 abused
amphetamines. None of them fulfilled criteria for drug-
induced psychosis. A detailed description of recruitment
criteria, clinical and demographic characteristics, and
methodology has been provided elsewhere.11
Diagnosis was confirmed according to the DSM-IV
criteria using the Kiddie Schedule for Affective Disorders
and Schizophrenia, Present and Lifetime version
(K-SADS-PL), Spanish adaptation.12 DSM-IV criteria
were applied also at 1-year follow-up. Psychopathology
was assessed with the Positive and Negative Syndrome
Scale (PANSS), and duration of untreated psychosis was
calculated at the first interview by asking about the first
appearance ever of positive psychotic symptoms within
a psychotic episode. At 1 year of follow up, 3 main diag-
nostic categories were established in the FEP group: schizo-
phrenia, psychotic bipolar disorder, and other psychoses
(including schizoaffective disorder: 7, 16.3%; psychotic dis-
order not otherwise specified: 15, 34.9%; depressive disor-
der with psychotic symptoms: 6, 14.0%; schizophreniform
disorder: 6, 14.0%; brief psychotic disorder: 3, 7.0%; obses-
sive compulsive disorder with psychotic symptoms:
2, 4.7%; 4, 9.35% without specific diagnostic because the
1-year reassessment could not be performed.
Parental socioeconomic status was assessed with the
Hollingshead-Redlich scale. The study was approved
by the Ethics and Clinical Research Boards of all hospi-
tals involved in the study. After complete description of
the study to the subjects, written informed consent was
obtained. All controls and patients met MRI safety
criteria.
MRI Acquisition
Five different scanning facilities contributed data to the
study: 2 Siemens Symphony, 2 General Electric Signa,
and 1 Philips ACS Gyroscan, all 1.5-T scanners. One
site (first site in table 2) received patients and controls
from 2 Psychiatric Units that were located in the same
city. Data were collected from each center and processed
at one site.13 Two MRI sequences were acquired in axial
orientation for each subject, a T1-weighted 3D gradient
echo (voxel size 1 3 1 3 1.5 mm) and a T2-weighted
Turbo-Spin-Echo (voxel size 1 3 1 3 3.5 mm). Full details
about the acquisition parameters at each site, comparabil-
ity between machines for this study, and the limitations
involved in the analysis of multicenter data are provided
in Reig et al.13 To minimize the effect of the multicenter
design, the sample of patients and controls were matched
within each of the 5 contributing institutions. The number
of subjects scanned at each site are provided in table 1.
Segmentation and Region of Interest Definition
MRI images were processed using locally developed soft-
ware incorporating a variety of image processing and
quantification tools.13,14 To obtain volume measure-
ments of themain brain lobes, we used amethod for semi-
automated segmentation of the brain based on the
Talairach proportional grid system, performed in native
space.15,16 Basically, a 2-step procedure was followed.14
First, an initial segmentation of cerebral tissues into
Multicenter Study in Children and Adolescent-Onset Psychosis
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GM, white matter (WM), and CSF was obtained using
SPM2 (Statistical Parametric Mapping; Wellcome Trust
Centre forNeuroimaging, London,UK; http://www.fil.ion
.ucl.ac.uk/spm) routines for multimodal (T1 and T2) seg-
mentation. Because of the multicenter setup, multimodal
tissue segmentation is more robust than single modality
(T1 only) with regards to image contrast–related differen-
ces between sites. This assumption was corroborated in
a previous study in which the repeatability of multimodal
(T1 and T2) and T1-only segmentation was compared
among the 5 scanners using the same methodology as in
this study.13 The SPM algorithm for tissue segmentation
includes a method to eliminate the effect of radio fre-
quency field inhomogeneities.17 In a second step, the
Talairach grid was built on the edited brain MRI by man-
ually selecting the position of the anterior and posterior
commissures (AC and PC) and a third point in the mid-
sagittal plane. The coordinates of these points serve to cal-
culate the transformation (rigid rotation) required to
comply with the Talairach orientation: to set the AC-
PC line in the axial horizontal plane and the interhemi-
spheric plane in the vertical orientation.18 Then, our soft-
ware application automatically finds the outer brain limits
in Talairach orientation, and 3D grids are built for each
brain. The Talairach grid obtained in this way represents
a piecewise linear transformation and a tessellation of the
brain into a 3D grid of 1056 cells representing homologous
brain regions across subjects.18 The region of interest
(ROI) measurements were obtained by superimposing
the 3D tissue masks corresponding to GM, WM, and
CSF onto each subject’s Talairach grid, where the ROIs
were defined as sets of Talairach grid cells (figure
1).13,15,16 Volume for each tissue type was measured on
this MRI by summing up the data from the Talairach
grid cells associated with each ROI.14 The validity of
the Talairach-based procedure as an automated segmen-
tation and quantification tool suitable for volumetric stud-
ies has already been proven,15,16 and it has been used in
other multicenter studies.19 In our implementation, all
manual procedures were performed by a single operator
blind to the origin of each scan, thus avoiding any poten-
tial interrater variability. The error due to manual inter-
vention in our segmentation procedures was highest for
CSF measurements (around 4%), whereas for GM was
less than 2% in all the ROIs studied.13
Measures
We chose to study the brain regions most likely to show
volume changes, as previously observed in first-episode
patients.7–9 The ROIs included in the analysis were the
frontal, parietal, and temporal lobes, defined using the
boundaries previously described for the Talairach
method.15 Whole-brain GM and CSF were also
Table 1. Sociodemographic and Clinical Characteristics of Patients and Controls
Controls (n = 94) Patients (n = 92)
Age (y) (mean, range, SD) 15.4, 19–9, 1.4 15.7, 18–9, 1.7 NS
Gender (male/female) 61/33 64/28 NS
Education (y) (mean, SD) 8.8, 1.4 8.3, 2.0 NS
Parental socioeconomic status (1/2/3/4/5) 10/23/24/11/26 19/29/21/11/12 NS
Handedness: right/left/mixed 87/5/2 85/7/0 NS
Race/ethnicity (Caucasian/Hispanic/
Black-African/Other)
86/6/2/0 82/5/1/4 NS
Duration of illness (mo) (mean, SD) 2.1, 1.7
Diagnosis (schizophrenia/bipolar/other
psychoses)
31/18/43
Duration of treatment (wk) (mean,
range, SD)
4.8, 65.0–0, 9.5
Treatment:quetiapine/olanzapine/
risperidone(mg, mean, SD)
21/23/48, 211.0/196.2/10.7, 5.0/3.4/1.6
Subjects per site 46/28/9/7/4 48/21/5/12/6 NS
Note: NS: nonsignificant differences.
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measured. Intracranial volume (ICV) was obtained by
adding the total GM, WM, and CSF volumes, including
the cerebellum. For each ROI, we obtained volumes for
each hemisphere and forGMandCSF. The occipital lobe
was not included in the study because of its relatively high
measurement error in multicenter data, which was 5.7%
in GM and 17% in CSF values.13 Subcortical and cere-
bellar regions were not measured because in our multi-
center setup, their segmentation using automated
methods would require a thorough study of compatibility
and validation. Multicentre reproducibility of WM was
nearly twice lower than of GM,13 thus volume data for
WM were not included in the study, also to reduce the
dimensionality of the analysis. In addition to these tech-
nical problems, a structural study of WM would have
been incomplete and inconclusive without data from
other sequences such as diffusion-weighted imaging
that provide functional information about connectivity.
Statistical Analysis
Differences between patients and controls in demo-
graphic data were assessed by Student’s t and chi-square
tests, according to the type of the variable.
Because age and total cranial size are known factors
affecting regional cerebral volumes, their effect was re-
moved using the residuals from the regression models
obtained from the group of healthy controls, separately
for each gender, following the procedure of Pfefferbaum
et al.20 After this correction, volume variables were
expressed as deviations (regression residuals) from the
expected volumes in healthy individuals of the same
age (in months) and brain size (ICV) as the patient.
Thus, negative residuals could be seen as volume deficits
relative to controls and vice versa. The comparative anal-
ysis of volume differences between groups was done using
these regression residuals for each variable, which is
equivalent to using brain size and age as covariates in
an ANCOVA model.
The age and ICV regression residuals obtained in the
previous step were used to test for volume differences be-
tween patients and controls by anANCOVAmodel using
scanner site as a factor of no interest in the analysis.13
Because of known differences in brainmorphometrics be-
tween males and females21 and also because we have
found significant group 3 gender interactions for some
variables, we did the comparison between patients and
controls separately for each gender. We discarded using
Table 2. Volume Measurements (in cm3) of Controls and Patients
Controls Patients
Controls/Patients
(Males)a
Females (n = 33) Males (n = 61) Females (n = 28) Males (n = 64)
Mean SD Mean SD Mean SD Mean SD
Age (y) 15.4 1.8 15.4 1.9 15.3 1.9 15.8 1.9
Intracranial volume 1432.8 103.0 1540.3 141 1366.8 114 1563.6 133
Total GM 769.8 71.3 847.9 87.9 724.8 88.0 832.2 81.3 ***
Total WM 379.9 39.3 410.9 53.2 376.8 67.0 417.1 47.4
Total CSF 283.0 45.4 281.4 50.3 264.5 63.3 314.1 60.2 ***
GM
Frontal, left 70.8 8.9 80.2 10.3 67.9 8.1 75.8 9.2 ***
Frontal, right 73.6 9.0 83.7 10.8 70.9 9.8 77.9 9.9 ***
Parietal, left 58.5 7.9 64.2 8.5 54.8 8.8 62.4 8.7 *
Parietal, right 59.0 7.7 64.5 8.9 55.4 10.0 62.0 8.0 ***
Temporal, left 77.1 7.3 84.4 8.4 72.1 10.1 84.9 9.1
Temporal, right 76.9 7.5 83.1 8.5 72.1 10.2 84.7 9.1
CSF
Frontal, left 28.2 5.9 27.5 7.0 26.6 9.0 31.9 8.3 ***
Frontal, right 29.9 6.2 28.5 6.8 28.0 9.3 33.6 8.6 ***
Parietal, left 24.9 6.3 23.4 6.7 22.4 7.2 26.0 6.1
Parietal, right 22.7 5.5 22.3 6.5 21.0 8.2 25.5 6.5 **
Temporal, left 23.2 3.9 23.0 4.0 21.7 5.1 25.8 5.2 ***
Temporal, right 21.9 3.8 21.4 4.4 20.1 4.5 24.3 5.7 ***
Note: GM, gray matter; WM, white matter; CSF, cerebrospinal fluid.
aANCOVA of male controls vs patients using residuals after correction for ICV, age, and scanner factors. No differences observed in
females.
***P < .001; **P < .01; *P < .05.
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a full factorial design including the interaction group 3
gender on the model because of the different sample
size for males and females, which makes an unbalanced
model that compromises the interpretation of factor
effects, specially for the interaction term. Another com-
parative analysis between patients and controls was also
done by subdividing the patient sample into 3 diagnostic
groups: schizophrenia, bipolar, and other psychosis. Dif-
ferences between these groups were tested using post hoc
procedures (Dunnett’s test) whenever the ANCOVA
model revealed significant differences between groups.
In variables showing significant differences between
group means, Cohen’s effect size (ES) were calculated
to provide an index of the magnitude of differences.
The association between symptom scores (PANSS posi-
tive, negative, and general scales) and volumetric varia-
bles (age and ICV residuals) was studied using
Pearson’s correlation. Normality of the distributions
and homoscedasticity of variance among groups was
checked prior to the analysis. Statistical analyses were
done using SAS 9.0 (Statistical Analysis System, Cary,
North Carolina), and a 2-tailed P-value lower than .05
was considered statistically significant.
Results
Sociodemographic and Clinical Characteristics
Patients and controls were not significantly different in
terms of age, sex, education, years of education, race,
or handedness (table 1). Duration of illness prior to the
MRI scan was very short (mean 2 months; table 1). No
differences were observed between male and female
patients regarding PANSS scores in total positive
(mean, SD: 14.0, 6.2 and 15.8, 6.5, respectively, for females
and males) or negative (mean, SD: 17.5, 6.9 and 17.4, 6.3,
respectively, for females and males) subscales.
Differences Between Patients and Controls
Results of the ANCOVA of age and ICV residuals using
scanner as factor of no interest suggest that only male
patients showed significant differences relative to con-
trols (table 2). Male patients showed smaller whole-brain
GM volume (F1,123 = 16.3; P < .0001; ES = 0.77) and
larger CSF volume (F1,123 = 20.3; P < .0001; ES =
0.81). GM volumes of male patients were smaller than
controls in the frontal lobe in both right (F1,123 = 28.2;
P < .0001; ES = 0.98) and left hemispheres
Fig. 1. Segmentation andQuantificationMethodBased on the Talairach Proportional Grid System. The figure shows a triplanar view of the
Talairach grid built in a particular brain. The colored set of grid cells define the frontal (red), parietal (pink), and temporal (blue) regions of
interest of the right hemisphere. Green color overlaid on the magnetic resonance imaging shows the segmentation of gray matter tissue.
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(F1,123 = 17.5; P < .0001; ES= 0.79) and in the parietal
lobe (right: F1,123 = 10.9, P = .0013, ES = 0.61; left:
F1,123 = 5.3, P = .0230, ES = 0.42). Male patients
also showed larger CSF volumes in the frontal (right:
F1,123 = 17.6, P < .0001, ES = 0.63; left: F1,123 = 11.4,
P = .0012, ES = 0.84), temporal (right: F1,123 = 20.3,
P < .0001, ES = 0.79; left: F1,123 = 21.8, P < .0001,
ES = 0.77), and right parietal (F1,123 = 8.3; P = .0047;
ES = 0.56) lobes (table 2). The statistical significance
of most of these differences persist even after a stringent
Bonferroni correction considering a total of 30 tests
(P = .0017).
Differences Between Patients Subgroups and Controls
Results of the post hoc Dunnett’s test revealed that male
schizophrenia patients showed significantly smaller
Table 3. Volume Measurements (in cm3) of Patients in Each Diagnostic Group, by Gender
Schizophrenia Bipolar Other Psychosis
Mean SD Mean SD Mean SD Schizophreniaa Bipolara
Other
Psychosisa
Males (n) 24 12 28
Age (y) 15.8 2.1 16.2 2.0 15.7 1.6
Intracranial volume 1577.8 151.6 1489.1 63.4 1582.0 128.0
Total GM 835.3 88.5 800.5 63.7 842.7 80.6 *** ***
Total WM 422.3 51.7 395.5 40.9 421.4 44.8
Total CSF 319.9 78.7 293.0 46.2 317.7 43.6 ** * ***
GM
Frontal, left 76.1 10.5 74.7 8.7 76.0 8.5 *** ***
Frontal, right 77.4 10.7 77.4 11.3 78.6 8.8 *** ***
Parietal, left 62.9 8.7 60.2 8.7 62.9 8.9
Parietal, right 62.2 8.1 60.1 8.5 62.6 8.0 ** **
Temporal, left 86.4 10.0 79.5 6.2 85.7 8.6
Temporal, right 85.3 9.6 79.8 6.7 86.1 9.1
CSF
Frontal, left 32.2 9.6 30.5 7.9 32.3 7.5 * * **
Frontal, right 32.6 9.5 31.9 7.0 35.3 8.3 * ** ***
Parietal, left 27.2 7.8 24.3 5.4 25.8 4.5
Parietal, right 25.4 8.1 24.9 5.5 25.9 5.1 * *
Temporal, left 26.9 6.7 23.0 3.9 26.0 3.7 *** ***
Temporal, right 24.9 7.4 21.6 4.0 24.8 4.0 *** ***
Females (n) 7 6 15
Age (y) 15.2 1.9 15.2 2.4 15.3 1.9
Intracranial volume 1437.1 144.0 1303.3 133.9 1358.9 84.3
Total GM 766.0 105.6 687.3 111.2 720.9 71.2
Total WM 377.8 41.2 365.6 77.7 380.1 75.1
Total CSF 293.2 53.1 250.3 72.3 257.7 64.7
GM
Frontal, left 69.9 7.5 64.7 10.0 68.2 7.9
Frontal, right 74.5 9.5 69.2 13.3 70.1 9.0
Parietal, left 56.1 10.8 50.6 11.3 55.6 7.3
Parietal, right 56.3 9.1 52.6 15.9 56.0 8.5
Temporal, left 77.8 10.9 66.3 11.3 71.7 8.7
Temporal, right 77.4 13.2 68.5 10.4 71.1 8.6
CSF
Frontal, left 33.8 11.0 21.4 7.2 25.5 7.2 *
Frontal, right 35.7 11.4 25.4 7.9 25.8 7.6 **
Parietal, left 25.9 6.5 22.2 7.8 21.1 7.3
Parietal, right 22.3 7.1 23.3 13.6 19.7 6.8
Temporal, left 23.9 2.9 18.2 4.0 22.0 5.7
Temporal, right 20.9 2.0 18.9 5.4 20.2 5.0
Abbreviations are explained in the first footnote to table 2.
aPost hoc Dunnett’s tests comparing each patient group vs controls using residuals after correction for intracranial volume, age, and
scanner factors.
***P < .001; **P < .01; *P < .05.
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whole-brainGM (P = .0008) and larger CSF volumes (P =
.0027) (table 3; figure 2) than controls. Male schizophre-
nia patients also showed smaller GM volumes in the fron-
tal (right:P< .0001; left:P = .0009) and right parietal lobe
(P = .0061) and larger CSF volumes in the temporal (right:
P = .0005; left: P = .0001) and frontal lobes (right:
P = .0261; left: P = .00147). The males in the other psy-
chosis group showed differences relative to controls in
the same ROIs as male schizophrenia patients (table 3;
figure 2), smaller whole-brain GM (P = .0008), larger
Fig. 2.ScatterPlotsShowing IndividualDataPoints IllustratingDistributionofGrayMatter (GM)andCerebrospinalFluid (CSF)Variables
in Male Subjects Showing the Most Significant Differences Relative to Controls (table 3). Volume data are expressed as residuals after
correction for intracranial volume, age, and scanner factors (see ‘‘Methods’’ for details). Dashed lines mark the mean for each group (þ,
controls; O, patients).
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CSF volume (P = .0001), smaller GM volume in the fron-
tal (right and left: P < .0001) and parietal (right: P =
.0045; left: P = .0187) lobes, and larger CSF volumes in
the frontal (right: P< .0001; left: P = .0047), right parietal
(P = .0111), and temporal lobes (right and left: P< .0001)
(table 3; figure 2). Bipolar male patients showed signifi-
cant differences from controls only for CSF values;
whole-brain (P = .0131), frontal (right P = .0017; left
P = .0134), and right parietal (P = .0110) (table 3; figure 2)
lobes. The same ANCOVA model testing for differences
between the 3 clinical subtypes revealed no significant dif-
ferences.
In female patients, only the schizophrenia group
showed significantly larger CSF volumes in the frontal
lobe (right: P = .0085; left: P = .0207), relative to controls
(table 3). However, these differences should be taken with
caution because of the small sample size of the patient
group (n = 7).
Association Between Volume and Symptom Scores
Inmale patients, the correlation analysis revealed a signif-
icant negative relationship between negative symptoms
and whole-brain GM volume (r = .292, P = .025). In
the ROI analysis of GM volumes, this correlation was
significant only in the parietal lobe (right: r = .399,
P = .002; left: r =.296, P = .023). This correlation seems
to be of the same nature for the 3 diagnostic groups
(figure 3). No correlation was observed between duration
of illness and volume measurements. In female patients,
no correlation between volume and symptoms nor with
duration of illness were observed.
Discussion
Several main findings emerge from this study. We found
that total, frontal, and parietal GM volumes are reduced
in males of first- and recent-onset episodes of psychosis
compared with controls and that total CSF volume, and
frontal, temporal, and right parietal CSF volumes are in-
creased. We also found that nonschizophrenia nonaffec-
tive psychosis group behaves similarly to schizophrenia in
terms of observed structural brain changes. Finally, we
have shown that in male patients, negative symptoms
have a negative correlation with total GM volume
from beginning phases of early-onset psychotic disorders.
Volumetric Findings
In this study, we observed volume differences in struc-
tures that have been associated with psychosis in different
stages of the disorder. Decreased GM and increased total
intracranial CSF have been repeatedly shown in cross-
sectional studies of adult samples, both in first episodes
and in chronic patients.22 Our sample contains, to our
knowledge, the largest recent and early-onset psychosis
sample reported in the literature. The results add to
our previous findings in a smaller sample, showing
that recent-onset schizophrenia adolescents had de-
creased frontal GM and increased total intracranial
CSF and left frontal CSF.7,10 The results also partially
replicate the few other early-onset studies available. In
a sample of chronic child-onset schizophrenia patients,
Rapoport and her team showed reduced GM and in-
creased CSF volume in the brains of those patients.3,6,23
This group showed only parietal deficits at baseline.
Frontal deficits were only significant at follow-up. This
frontal deficit could be an age effect, meaning that it
is plausible that only at the developmental time when
frontal GM reduction occurs physiologically during ad-
olescence,21 does the excessive loss associated with
schizophrenia take place. The mean age of the National
Institute of Mental Health sample was 13 years at base-
line and 17 years at follow-up, while themean age at base-
line in our sample was around 15 years. The former
Fig. 3. Plots showing significant relationships between negative
symptomsandGMvolumes of parietal lobes inmale patients (right:
r 5 .399, P 5 .002; left: r 5 .296, P 5 .023). Data points show
volume data expressed as residuals after correction for intracranial
volume, age, and scanner factors (see ‘‘Methods’’ for details).
Patients are labeled by clinical subtypes (S: schizophrenia
[continuous line]; B: bipolar disorder [dotted line]; O: others
[dashed line]).
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sample had a duration of illness before baseline of around
3 years, and ours was a very recent-onset sample, with less
than 3-month duration of illness, which argues against
frontal deficit being just an effect of chronicity. The Ox-
ford group reporting on a sample of 16 adolescents with
first episodes of schizophrenia, with a duration of illness
of around 18 months, showed only larger ventricular vol-
umes and changes in left temporal lobe that were present
from the beginning of the disorder.8,9 Relative to these
other studies, our sample of patients is of particular in-
terest because of the large sample size and the short pe-
riod between the appearance of positive symptoms and
MRI scanning.
Timing of GM Reduction and CSF Increase
Results from the literature regarding CSF enlargement
are conflicting in their interpretation. CSF enlargement
has been shown from the beginning of illness and at
all ages of onset. It has usually been considered suggestive
of degeneration.4 However, some authors argue that the
differences between the brains of schizophrenia patients
at the beginning of the illness and those of controls reflect
abnormal neurodevelopment.24 Trying to determine
when the brain reduction occurs, Woods developed a se-
ries of formulas that are based on the assumptions that
maximum cranial volume is driven by brain growth and
that, once the cranium reaches its peak size, this is not
reduced. Using this approach, the authors found a quan-
titatively similar reduction of volume before and after the
brain reaches its maximum capacity.25 The timing of the
GM reduction cannot be concluded from a cross-sec-
tional study such as ours, but we hereby show that the
GM reduction is present from the first stages of the dis-
order, which is in agreement with other studies.7,10 Lon-
gitudinal studies suggest that the rate of cortical loss seen
in child-onset schizophrenia during adolescence reaches
a plateau during early adulthood.26 In conclusion, several
studies, including ours, concur that it is during preado-
lescence or adolescence when exaggerated GM loss takes
place in the frontal lobe.
The consideration of GM loss as degenerative or
developmental is to some extent conceptual. Some
maturational processes continue well after infancy or ad-
olescence. Early insults (including prenatal) can have
a pruning or regressive effect, as in late maturational pro-
cesses. Some authors explicitly call neurodegenerative
those changes occurring in adolescence in which a greater
than expected disruption in the process of synaptic loss is
found,27 while others usually call developmental any
event occurring before maturation is completed.24
Diagnostic-Related Differences
In our sample, both reduced GM and enlarged sulcal CSF
were found in schizophrenia and ‘‘other psychosis’’
patients, but these differences were smaller in bipolar
patients. This finding supports previous findings showing
the relative specificity of these 2 markers to schizophrenia28
in comparison with bipolar disorders. Two studies have
shown that in severe bipolar patients ventricular enlarge-
ment may also be present.29 In fact, an association between
number of affective episodes and ventricular volume has
been shown in 2 different studies30,31 and may underlie
the ventricular enlargement shown in those studies.
The fact that the ‘‘other psychosis’’ group shows find-
ings similar to the schizophrenia group probably reflects
the heterogeneity of this subgroup, comprising 6 different
diagnoses (see ‘‘Methods’’). In addition, the stability of
the nonaffective and nonschizophrenia psychotic disor-
ders in adolescence, contrary to the schizophrenia and bi-
polar disorder diagnosis, is in fact very low.32,33 We were
very restrictive in delimiting the schizophrenia and bipolar
groups, and it is expected that some psychotic depressions
in the ‘‘others’’ group will subsequently change to the bi-
polar group and that schizophreniform and schizoaffec-
tive patients will change to the schizophrenia group.
Early age of onset could also underlie and be responsible
for the similarities in our findings between different diag-
nostic groups. Decreased GM can be an indicator of un-
specific developmental deviations, which could cause any
genetically driven disorder to be expressed earlier in life.
Vulnerable brains may express psychotic disorders earlier.
Gender Issues
We found no differences in female patients in general
compared with female controls. Within females, only
the schizophrenia group showed minor differences in
CSF of the frontal lobe relative to controls. Studies
have systematically found more anomalies in males
than in females. This could be because the male brain
is more vulnerable than the female brain or it may just
reflect false negatives in the analysis of females related
to sample size. However, in this study, our sample should
be large enough to show differences, if they were in the
same range as those found in males. Although the liter-
ature shows gender differences in clinical features such as
earlier age at onset, poorer premorbid adjustment, more
brain abnormalities, and poorer outcome in males, the
findings have been considered consistent with normal
sexual dimorphism in brain development and gender-
assigned social roles and do not invoke the need for
a sex-specific etiological factor.34 Factors related to gen-
der and pubertal status in the evolution of the illness and
hormonal status at the time of MRI evaluation should be
considered. In fact, physiological changes might explain
differences as large as 10% in certain CSF volumes in
females.35 This, however, needs further research.
The assumption that brain or brain region size or vol-
ume is associated with integrity, function, or level of mat-
uration is not to be taken for granted. Many examples
undermine this assumption. In fact, longitudinal studies
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have been contradictory in correlating GM loss with
prognosis.5,6,36,37
Psychopathology and Brain Volumes
The finding that negative symptoms negatively correlate
with total GM and CSF volume is consistent with previ-
ous findings in early-onset3,6,38 and adult samples.39 How-
ever, this association between morphometric and clinical
variables should be taken with caution because the overall
strength of these correlations was low. Only the right pa-
rietal lobe would persist after a Bonferroni correction for
multiple comparisons. This result converges with the lit-
erature findings that associate parietal deficits with the
deficit syndrome in schizophrenia studies.40,41
Limitations
This study has several limitations. The first is the multi-
center nature of study. Although this made it possible to
obtain data froma large number of patients, the use of dif-
ferent MRI systems adds an additional source of error in
the analysis. This error due to scanner effect was assessed
in a prior study13 and has been explicitly addressed by
including scanner site as a covariate in the models tested.
Also due to this limitation, data from the occipital lobes
were excluded from the analysis because of the high error
observed in our multicenter reliability study.13 The sec-
ond main limitation is the small sample size of clinical
subtypes within patients for each gender, which limited
the results of the post hoc analyses. This limitation
had a stronger effect in the case of female sample. How-
ever, the statistical power of the female sample in the re-
gional GM values was higher than 80% (mean and SD
data from table 2, assuming an alpha error level of
20%). Finally, the findings on the group of bipolars in-
cluded may not be generalized to nonpsychotic bipolars.
Despite these limitations, within the neuroimaging lit-
erature, our study includes a relatively large sample of
first episodes of early-onset psychosis and provides
further data supporting frontal and parietal GM deficits
within the FEP.
Funding
Ministerio de Sanidad y Consumo; Instituto de Salud
Carlos III (Red de Investigacio´n G03/032, RETICS
RD06/0011 [REM-TAP Network], FIS PI052271); Con-
sorcio Para El Desarrollo De Tecnologı´as Avanzadas De
Imagen En Medicina Programa Consorcios Estrate´gicos
Nacionales en Investigacio´n Te´cnica, Ministerio de
Industria; Fundacio´n Alicia Koplowitz; Centro de Inves-
tigacio´n Biome´dica en Red de Salud Mental, Instituto de
Salud Carlos III, Ministerio de Ciencia e Innovacio´n.
Support also given by the Generalitat de Catalunya to
the Child Psychiatry and Psychology Group (2009
SGR 1119).
Acknowledgments
All authors report no biomedical financial interests or
potential conflicts of interest.
References
1. Greenstein D, Lerch J, Shaw P, et al. Childhood onset schizo-
phrenia: cortical brain abnormalities as young adults. J Child
Psychol Psychiatry. 2006;47:1003–1012.
2. Sowell ER, Toga AW, Asarnow R. Brain abnormalities ob-
served in childhood-onset schizophrenia: a review of the
structural magnetic resonance imaging literature. Ment Re-
tard Dev Disabil Res Rev. 2000;6:180–185.
3. Rapoport JL, Giedd J, Kumra S, et al. Childhood-onset
schizophrenia. Progressive ventricular change during adoles-
cence. Arch Gen Psychiatry. 1997;54:897–903.
4. Arango C, McMahon RP, Lefkowitz DM, Pearlson G,
Kirkpatrick B, Buchanan RW. Patterns of cranial, brain and
sulcal CSF volumes in male and female deficit and nondeficit
patients with schizophrenia. Psychiatry Res. 2008;162:91–100.
5. Thompson PM, Vidal C, Giedd JN, et al. Mapping adoles-
cent brain change reveals dynamic wave of accelerated gray
matter loss in very early-onset schizophrenia. Proc Natl
Acad Sci U S A. 2001;98:11650–11655.
6. Sporn AL, Greenstein DK, Gogtay N, et al. Progressive brain
volume loss during adolescence in childhood-onset schizo-
phrenia. Am J Psychiatry. 2003;160:2181–2189.
7. Moreno D, Burdalo M, Reig S, et al. Structural neuroimaging
in adolescents with a first psychotic episode. J Am Acad Child
Adolesc Psychiatry. 2005;44:1151–1157.
8. James AC, Javaloyes A, James S, Smith DM. Evidence for
non-progressive changes in adolescent-onset schizophrenia:
follow-up magnetic resonance imaging study. Br J Psychiatry.
2002;180:339–344.
9. James AC, James S, Smith DM, Javaloyes A. Cerebellar, pre-
frontal cortex, and thalamic volumes over two time points in
adolescent-onset schizophrenia. Am J Psychiatry. 2004;
161:1023–1029.
10. Reig S, Moreno C, Moreno D, et al. Progression of brain vol-
ume changes in adolescent-onset psychosis. Schizophr Bull.
2009;35:233–243.
11. Castro-Fornieles J, Parellada M, Gonzalez-Pinto A, et al. The
child and adolescent first-episode psychosis study (CAFEPS):
design and baseline results. Schizophr Res. 2007;91:226–237.
12. Soutullo CA. Schedule for Affective Disorders and Schizo-
phrenia for School-Age Children (K-SADS), adapted to
Spanish fromSpain. http://www.cun.es/la-clinica/departamentos-
y-servicios-medicos/psiquiatria-y-psicologia-medica/mas-sobre-
el-departamento/unidades/psiquiatria-infantil-y-adolescente.
Accessed July 2008.
13. Reig S, Sanchez-Gonzalez J, Arango C, et al. Assessment of
the increase in variability when combining volumetric data
from different scanners. Hum Brain Mapp. 2009;30:355–368.
14. Desco M, Pascau J, Reig S, et al. Multimodality image quan-
tification using Talairach grid. Paper presented at: Proceedings
of SPIE Medical Imaging. February 2001; San Diego, CA.
15. Andreasen NC, Rajarethinam R, Cizadlo T, et al. Automatic
atlas-based volume estimation of human brain regions from
MR images. J Comput Assist Tomogr. 1996;20:98–106.
16. Kates WR, Warsofsky IS, Patwardhan A, et al. Automated
Talairach atlas-based parcellation and measurement of cere-
bral lobes in children. Psychiatry Res. 1999;91:11–30.
1279
Multicenter Study in Children and Adolescent-Onset Psychosis
 at U
niversidad de N
avarra on July 8, 2014
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
17. Ashburner J, Friston KJ. Multimodal image coregistration
and partitioning—a unified framework. Neuroimage. 1997;
6:209–217.
18. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the
Human Brain. New York, NY: Thieme Medical; 1988.
19. Patwardhan AJ, Eliez S, Warsofsky IS, et al. Effects of image
orientation on the comparability of pediatric brain volumes
using three-dimensional MR data. J Comput Assist Tomogr.
2001;25:452–457.
20. Pfefferbaum A, Lim KO, Zipursky RB, et al. Brain gray and
white matter volume loss accelerates with aging in chronic
alcoholics: a quantitative MRI study. Alcohol Clin Exp Res.
1992;16:1078–1089.
21. Lenroot RK, Gogtay N, Greenstein DK, et al. Sexual dimor-
phism of brain developmental trajectories during childhood
and adolescence. Neuroimage. 2007;36:1065–1073.
22. Hulshoff Pol HE, Kahn RS. What happens after the first
episode? A review of progressive brain changes in chronically
ill patients with schizophrenia. Schizophr Bull. 2008;34:
354–366.
23. Gogtay N, Sporn A, Clasen LS, et al. Comparison of progres-
sive cortical gray matter loss in childhood-onset schizophre-
nia with that in childhood-onset atypical psychoses. Arch
Gen Psychiatry. 2004;61:17–22.
24. Weinberger DR, Marenco S. Schizophrenia as a neurodeve-
lopmental disorder. In: Weinberger D, ed. Schizophrenia.
2nd ed. Malden, MA: Blackwell Publishing; 2003:326–348.
25. Narr KL, Toga AW, Szeszko P, et al. Cortical thinning in cin-
gulate and occipital cortices in first episode schizophrenia.
Biol Psychiatry. 2005;58:32–40.
26. Arango C, Kahn R. Progressive brain changes in schizophre-
nia. Schizophr Bull. 2008;34:310–311.
27. Woods BT. Is schizophrenia a progressive neurodevelopmen-
tal disorder? Toward a unitary pathogenetic mechanism. Am
J Psychiatry. 1998;155:1661–1670.
28. McDonald C, Marshall N, Sham PC, et al. Regional brain
morphometry in patients with schizophrenia or bipolar disor-
der and their unaffected relatives. Am J Psychiatry.
2006;163:478–487.
29. Kempton MJ, Geddes JR, Ettinger U, Williams SC,
Grasby PM. Meta-analysis, database, and meta-regression
of 98 structural imaging studies in bipolar disorder. Arch
Gen Psychiatry. 2008;65:1017–1032.
30. Brambilla, Harenski K, Nicoletti M, et al. MRI study of pos-
terior fossa structures and brain ventricles in bipolar patients.
J Psychiatr Res. 2001;35:313–322.
31. Strakowski SM, DelBello MP, Zimmerman ME, et al. Ven-
tricular and periventricular structural volumes in first- versus
multiple-episode bipolar disorder. Am J Psychiatry.
2002;159:1841–1847.
32. Fraguas D, de Castro MJ, Medina O, et al. Does diagnostic
classification of early-onset psychosis change over follow-
up? Child Psychiatry Hum Dev. 2008;39:137–145.
33. Hollis C. Adult outcomes of child- and adolescent-onset
schizophrenia: diagnostic stability and predictive validity.
Am J Psychiatry. 2000;157:1652–1659.
34. Todd J, Michie PT, Jablensky AV. Association between re-
duced duration mismatch negativity (MMN) and raised tem-
poral discrimination thresholds in schizophrenia. Clin
Neurophysiol. 2003;114:2061–2070.
35. Teasdale GM, Grant R, Condon B, et al. Intracranial CSF vol-
umes: natural variations and physiological changes measured
by MRI. Acta Neurochir Suppl (Wien). 1988;42:230–235.
36. van Haren NE, Pol HE, Schnack HG, et al. Progressive brain
volume loss in schizophrenia over the course of the illness: ev-
idence of maturational abnormalities in early adulthood. Biol
Psychiatry. 2008;63:106–113.
37. Gur RE, Cowell P, Turetsky BI, et al. A follow-up magnetic
resonance imaging study of schizophrenia. Relationship of
neuroanatomical changes to clinical and neurobehavioral
measures. Arch Gen Psychiatry. 1998;55:145–152.
38. Alaghband Rad J, McKenna K, Gordon CT, et al. Childhood-
onset schizophrenia: the severity of premorbid course. J Am
Acad Child Adolesc Psychiatry. 1995;34:1273–1283.
39. Gur RE, Mozley PD, Shtasel DL, et al. Clinical subtypes of
schizophrenia: differences in brain and CSF volume. Am J
Psychiatry. 1994;151:343–350.
40. Lahti AC, Weiler MA, Holcomb HH, Tamminga CA,
Carpenter WT, McMahon R. Correlations between rCBF
and symptoms in two independent cohorts of drug-free
patients with schizophrenia. Neuropsychopharmacology.
2006;31:221–230.
41. Tamminga CA, Thaker GK, Buchanan R, et al. Limbic sys-
tem abnormalities identified in schizophrenia using positron
emission tomography with fluorodeoxyglucose and neocorti-
cal alterations with deficit syndrome. Arch Gen Psychiatry.
1992;49:522–530.
1280
S. Reig et al.
 at U
niversidad de N
avarra on July 8, 2014
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
